With regulators, payers, providers and patients demanding better evidence of safety and effectiveness to inform their decision-making, the diabetes landscape is becoming increasingly complex. But it’s also becoming an area of greater opportunity for drug, device and diagnostic developers who can quickly determine the right questions and deliver the right answers when it comes to proving tangible real-world value. Quintiles can help you achieve this by providing access to the therapeutic expertise and real-world data required to build a value story that resonates with stakeholders.